Trademark search
The 50 closest matches for of record for one attorney.
| Mark | Status | Office | Owner | Classes | Filed |
|---|---|---|---|---|---|
| STRATASTEP | abandoned | USPTO | Amylin Pharmaceuticals, LLC | 5 | 2014-01-22 |
| GUIDEPEN | abandoned | USPTO | Amylin Pharmaceuticals, LLC | 5 | 2014-01-16 |
| PENLOGIC | abandoned | USPTO | Amylin Pharmaceuticals, LLC | 5 | 2014-01-16 |
| FORXIGA | cancelled | USPTO | Astrazeneca AB | 5 | 2013-12-16 |
| APMETEM | abandoned | USPTO | Astrazeneca AB | 5 | 2013-12-09 |
| FURXIGA | abandoned | USPTO | Astrazeneca AB | 5 | 2013-08-27 |
| SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS | abandoned | USPTO | Astrazeneca AB | 42 | 2013-08-12 |
| DELTA DIABETES EXCHANGE: LEARNING THROUGH AWARENESS | abandoned | USPTO | Astrazeneca AB | 9, 16, 42, 44 | 2013-07-10 |
| ADVANCING DIABETES CARE | abandoned | USPTO | Bristol-Myers Squibb Company | 5, 16, 41, 42, 44 | 2013-06-03 |
| ADVANCING DIABETES CARE | abandoned | USPTO | Bristol-Myers Squibb Company | 5, 16, 41, 42, 44 | 2013-04-01 |
| EQUIDACENT | abandoned | USPTO | Astrazeneca AB | 5 | 2013-01-10 |
| BYDUREON SILQ | abandoned | USPTO | Amylin Pharmaceuticals, Inc. | 5 | 2012-06-20 |
| BYDUREON WYSP | abandoned | USPTO | Amylin Pharmaceuticals, Inc. | 5 | 2012-06-20 |
| BYDUREON XUSPEN | abandoned | USPTO | Amylin Pharmaceuticals, Inc. | 5 | 2012-06-20 |
| BYDUREON WHISPEN | abandoned | USPTO | Amylin Pharmaceuticals, Inc. | 5 | 2012-06-20 |
| DECLARE D | abandoned | USPTO | Astrazeneca AB | 42 | 2012-04-18 |
| FORSYNZIG | abandoned | USPTO | Bristol-Myers Squibb Company | 5 | 2012-02-22 |
| THE WAY YOU GET THERE MATTERS | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 44 | 2012-02-09 |
| THE WAY YOU GET THERE MATTERS. | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 44 | 2012-02-09 |
| [Design Mark] | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 44 | 2012-02-09 |
| BIFORXI | abandoned | USPTO | Astrazeneca AB | 5 | 2012-02-02 |
| DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS | abandoned | USPTO | Astrazeneca AB | 42 | 2012-01-26 |
| ALSUSTEZ | abandoned | USPTO | Astrazeneca AB | 5 | 2012-01-24 |
| [Design Mark] | abandoned | USPTO | Astrazeneca AB | 5 | 2011-07-14 |
| EPLYMULT | abandoned | USPTO | Bristol-Myers Squibb Company | 5 | 2011-06-28 |
| AMYLIN | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 42 | 2011-06-13 |
| BYPERSTA | abandoned | USPTO | Amylin Pharmaceuticals, Inc. | 5 | 2011-05-25 |
| BYETTA | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 5 | 2011-03-10 |
| SYMLIN SUPPORT PROGRAM | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 44 | 2011-03-02 |
| KOMBOGLYZE | abandoned | USPTO | Astrazeneca AB | 5 | 2011-02-24 |
| TUNING IN TO THE SYMLIN AND INSULIN PARTNERSHIP | cancelled | USPTO | Amylin Pharmaceuticals, LLC | 44 | 2011-02-17 |
| FORZIGA | abandoned | USPTO | Astrazeneca AB | 5 | 2010-12-02 |
| KOMBIGLYZE XR | abandoned | USPTO | Astrazeneca AB | 5 | 2010-11-09 |
| ONGLYZA | cancelled | USPTO | Astrazeneca AB | 16 | 2010-10-27 |
| CHALLENGING SCIENCE. CHANGING LIVES. | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 44 | 2010-09-20 |
| EBISTRIDE | abandoned | USPTO | Astrazeneca AB | 5 | 2010-09-02 |
| EBYSTRIDE | abandoned | USPTO | Astrazeneca AB | 5 | 2010-09-02 |
| BYONTIMET | abandoned | USPTO | Astrazeneca AB | 5 | 2010-09-02 |
| GLUCLIPSE | abandoned | USPTO | Astrazeneca AB | 5 | 2010-09-01 |
| YONTEGO | abandoned | USPTO | Astrazeneca AB | 5 | 2010-08-17 |
| BYDUREON ONCE-WEEKLY STEADY SUPPORT | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 44 | 2010-08-09 |
| DIABETES LIFE HARMONIZED | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 9 | 2010-06-10 |
| DIABETES LIFE HARMONIZED T2D HEALTH | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 9 | 2010-06-10 |
| DIABETES LIFE HARMONIZED | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 9 | 2010-06-10 |
| EXSCEL | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 42 | 2010-06-03 |
| CREATUS COME COLLABORATE GROW | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 41, 44 | 2010-06-02 |
| CREATUS COME COLLABORATE GROW | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 41, 44 | 2010-06-02 |
| DIABETES CLOSE TO THE HEART | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 41 | 2010-05-26 |
| DIABETES CLOSE TO THE HEART | cancelled | USPTO | Amylin Pharmaceuticals, Inc. | 41 | 2010-05-26 |
| DECELDA | abandoned | USPTO | Astrazeneca AB | 5 | 2010-05-21 |